Protective effects of arecanut seed phenols in retinoic acid induced osteoporosis and the potential mechanisms explored by network pharmacology
- PMID: 39449745
- PMCID: PMC11499182
- DOI: 10.3389/fendo.2024.1472146
Protective effects of arecanut seed phenols in retinoic acid induced osteoporosis and the potential mechanisms explored by network pharmacology
Abstract
Background: Arecanut seed is an important traditional medicine in Southeast Asia. It has been presented in a clinical formula to treat osteoporosis (OP) in China. Arecanut seed is abundant in phenols. However, most of current studies mainly focused on estrogen-deficient osteoporosis (OP) model of arecanut seed phenols (ASP), there is still a lack of roundly research about molecular mechanism of ASP therapy on OP and its influence on in drug-induced bone loss.
Materials and methods: To explore potential molecular mechanisms and the effects of ASP on OP, network pharmacology, molecular docking methods and a retinoic acid-induced OP rat model were employed in this study. According to the network pharmacology method, OP related targets and ASP compound related targets were collected from databases to obtain hub targets and top active chemicals in ASP treating OP. The potential therapic pathways were also calculated. Binding capacities of top active chemicals to hub targets were analyzed by molecular dock assay. In the animal experiment, osteocalcin (OCN) levels and alkaline phosphatase (ALP) activity in serum of all the rats were determined. The views of bone section were stained to observe the bone micro-structure of ASP affects. Bone mineral density (BMD), cortical bone thickness (CBT), area ratio of bone cortex (CAR) and area ratio of bone trabecula (TAR) were obtained from micro computed tomography to evaluate the effectiveness of ASP on bone loss.
Conclusion: Three hub genes and three top active compounds were screened by network pharmacology analysis and they combined well with each other. ASP had positive effects on alleviating RA-induced bone loss by regulating the expression of the hub genes. Signals in IL-17 pathway were predicted and primarily verified being potential targets in ASP treating OP.
Keywords: arecanut seed; molecular docking; network pharmacology; osteoporosis; phenols.
Copyright © 2024 Tang, Sun, Song and Chen.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures









Similar articles
-
The therapeutic mechanism of Compound Lurong Jiangu Capsule for the treatment of cadmium-induced osteoporosis: network pharmacology and experimental verification.Front Endocrinol (Lausanne). 2024 Jul 10;15:1331488. doi: 10.3389/fendo.2024.1331488. eCollection 2024. Front Endocrinol (Lausanne). 2024. PMID: 39050570 Free PMC article.
-
Mongolian medicine Sugemule-7 decoction prevents osteoporosis via Erk1/2 and p38 MAPK signaling pathways according to network pharmacology analysis.Int J Biol Macromol. 2025 Mar;292:139166. doi: 10.1016/j.ijbiomac.2024.139166. Epub 2024 Dec 30. Int J Biol Macromol. 2025. PMID: 39743063
-
Mechanism of action of Sambucus williamsii Hance var. miquelii in the treatment of osteoporosis analyzed by UHPLC-HRMS/MS combined network pharmacology and experimental validation.Fitoterapia. 2024 Jul;176:106003. doi: 10.1016/j.fitote.2024.106003. Epub 2024 May 8. Fitoterapia. 2024. PMID: 38729247
-
Effects of resveratrol in an animal model of osteoporosis: a meta-analysis of preclinical evidence.Front Nutr. 2023 Jul 27;10:1234756. doi: 10.3389/fnut.2023.1234756. eCollection 2023. Front Nutr. 2023. PMID: 37575330 Free PMC article.
-
Antiosteoporosis Effect and Possible Mechanisms of the Ingredients of Fructus Psoraleae in Animal Models of Osteoporosis: A Preclinical Systematic Review and Meta-Analysis.Oxid Med Cell Longev. 2021 Nov 24;2021:2098820. doi: 10.1155/2021/2098820. eCollection 2021. Oxid Med Cell Longev. 2021. PMID: 34868453 Free PMC article.
References
-
- Song F, Tang MM, Wang H, Zhang Y, Zhu KX, Chen X, et al. . UHPLC-MS/MS identification, quantification of flavonoid compounds from Areca catechu L. extracts and in vitro evaluation of antioxidant and key enzyme inhibition properties involved in hyperglycemia and hypertension. Ind Crops Prod. (2022) 189:115787. doi: 10.1016/j.indcrop.2022.115787 - DOI
-
- Sandhiutami NMD, Fahleni F, Miftahurrohmah N, Widhiyasari NKA, Azalia A, Amalia I. Enhanced wound healing effect of Areca catechu L. ointment via antibacterial activity and anti-inflammatory process at grade IIA burns in rats. J Herbmed Pharmacol. (2023) 12:388–98. doi: 10.34172/jhp.2023.42 - DOI
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous